Publications

Methods

Sjölander A. (In press). Sharp bounds for causal effects based on Ding and VanderWeele’s sensitivity parameters. Journal of Causal Inference.

Sjölander A, Frisell T, Öberg S, Wang Y, Hägg S. (2024). Combining Mendelian randomization with the sibling comparison design. Statistics in Medicine 43(4), 731-755.

Gabriel EE, Sachs MC, Martinussen T, Waernbaum I, Goetghebeur E, Vansteelandt S, Sjölander A. (2024). Inverse probability of treatment weighting with generalized linear outcome models for doubly robust estimation. Statistics in Medicine 43(3), 534-547.

Vancak V, Sjölander A. (2023). Sensitivity analysis of G-estimators to invalid instrumental variables. Statistics in Medicine 42(23), 4257-4281.

Sjölander A, Gabriel EE, Ciocanea-Teodorescu I. (2023). Target parameters and bias in non-causal change-score analyses with measurement errors. European Journal of Epidemiology 38(5), 501-509.

Gabriel EE, Sjölander A, Follmann Dean A, Sachs MC. (2023). Cross direct effects in settings with two mediators. Biostatistics 24(4), 1017-1030.

Gabriel EE, Sachs MC, Sjölander A. (2023). Sharp nonparametric bounds for decomposition effects with two binary mediators. Journal of the American Statistical Association 118(544), 2446-2453.

Gabriel EE, Sjölander A, Sachs MC. (2023). Nonparametric bounds for causal effects in imperfect randomized experiments. Journal of the American Statistical Association 118(541), 684-692.

Brand A, Sachs M, Sjölander A, Gabriel EE. (2023). Confirmatory prediction-driven RCTs in comparative effectiveness settings for cancer treatment. British Journal of Cancer 128(7), 1278-1285.

Sachs MC, Jonzon G, Sjölander A, Gabriel EE. (2023). A general method for deriving tight symbolic bounds on causal effects. Journal of Computational and Graphical Statistics 32(2), 567-576.

Sjölander A. (2023). Selection bias with outcome-dependent sampling. Epidemiology 34(2), 186-191.

Sjölander A, Gabriel EE, Ciocanea-Teodorescu I. (2022). Sensitivity analysis for causal effects with generalized linear models. Journal of Causal Inference 10(1), 441-479.

Sjölander A, Pena JM, Gabriel EE. (2022). Bias results for nondifferential mismeasurement of a binary confounder. Statistics and Probability Letters 186.

Hössjer O, Sjölander A. (2022). Sharp lower and upper bounds for the covariance of bounded random variables. Statistics and Probability Letters 182.

Ciocanea-Teodorescu I, Gabriel EE, Sjölander A. (2022). Sensitivity analysis for unmeasured confounding in the estimation of marginal causal effects. Biometrika 109(4), 101-1116.

Sjölander A, Greenland S. (2022). Are E-values too optimistic or too pessimistic? Both and neither! International Journal of Epidemiology 51(2), 355-363.

Sjölander A, Öberg S, Frisell T. (2022). Generalizability and effect measure modification in sibling comparison studies. European Journal of Epidemiology 37(5), 461-476.

Gabriel EE, Sachs MC, Sjölander A. (2022). Causal bounds for outcome-dependent sampling in observational studies. Journal of the American Statistical Association 117(538), 939-950.  

Sjölander A, Frisell T, Öberg A. (2022). Sibling comparison studies. Annual Review of Statistics and its Applications 9, 71-94.

Pena JM, Balgi S, Sjölander A, Gabriel EE. (2021). On the bias of adjusting for a non-differentially mismeasured discrete confounder. Journal of Causal Inference 9(1), 221-249.

Sjölander A, Hössjer O. (2021). Novel bounds for causal effects based on sensitivity parameters on the risk difference scale. Journal of Causal Inference 9(1), 190-210.

Ciocanea-Teodorescu I, Nason M, Sjölander A, Gabriel EE. (2021). Adjustment for disease severity in the test-negative study design. American Journal of Epidemiology 190(9), 1882-1889.

Sjölander A, Ciocanea-Teodorescu I. (2021). A cautionary note on a recently proposed sensitivity analysis for unmeasured confounding. International Journal of Epidemiology 50(3), 711-716.

Sjölander A. (2021). Estimation of marginal causal effects in the presence of confounding by cluster. Biostatistics 22(3), 598-612.

Sjölander A. (2020). A note on a sensitivity analysis for unmeasured confounding, and the related E-value. Journal of Causal Inference 8(1), 229-248.

Sjölander A. (2020). A cautionary note on extended Kaplan-Meier curves for time-varying covariates. Epidemiology 31(4), 517-522.

Sachs MC, Sjölander A, Gabriel EE. (2020). Aim for clinical utility, not just predictive accuracy. Epidemiology 31(3), 359-364.

Dahlqwist E, Kutalik Z, Sjölander A. (2020). Using instrumental variables to estimate the attributable fraction. Statistical Methods in Medical Research 29(8), 2063-2073.

D’Onofrio BM, Sjölander A, Lahey BB, Lichtenstein P, Öberg AS. (2020). Accounting for confounding in observational studies. Annual Review of Clinical Psychology 16, 25-48.

Sjölander A, Martinussen T. (2019). Instrumental variable estimation with the R package ivtools. Epidemiologic Methods 8(1), 1-20.

Sjölander A, Vansteelandt S. (2019). Frequentist vs Bayesian frameworks for multiple testing. European Journal of Epidemiology 34(9), 809-821.

Zetterqvist J, Vermeulen K, Vansteelandt S, Sjölander A. (2019). Doubly robust conditional logistic regression. Statistics in Medicine 38(23), 4749-4760.

Dahlqwist E, Magnusson KEP, Pawitan Y, Sjölander A. (2019). On the relationship between the heritability and the attributable fraction. Human Genetics 138(4), 425-435.

Sjölander A, Ning Y. (2019). A general and robust estimation method for the case-time-control design. Sociological Methodology 49(1), 349-365.

Dahlqwist E, Pawitan Y, Sjölander A. (2019). Regression standardization and attributable fraction estimation with between-within frailty models for clustered survival data. Statistical Methods in Medical Research 28(2), 462-485.

Sjölander A. (2018). Mediation analysis with attributable fractions. Epidemiologic Methods 7(1).

Sjölander A. (2018). Estimation of causal effect measures with the R-package stdReg. European Journal of Epidemiology 33(9), 847-858.

Lee W, Sjölander A, Pawitan Y. (2018). Likelihood-based inference for bounds of causal parameters. Statistics in Medicine 37(30), 4695-4706.

Sjölander A, Zetterqvist J. (2017). Confounders, mediators or colliders – What types of shared covariates does the sibling comparison design control for? Epidemiology 28(4), 540-547.

Sjölander, A. (2017). The case-time-control method for non-binary exposures. Sociological Methodology 47(1), 182-211.

Sjölander A, Vansteelandt S. (2017). Doubly robust estimation of attributable fractions in survival analysis. Statistical Methods in Medical Research 26(2), 948-969.

Dahlqwist E, Zetterqvist J, Pawitan Y, Sjölander A. (2016). Model-based estimation of the attributable fraction for cross-section, case-control, and cohort studies with the R package AF. European Journal of Epidemiology 31(6), 575-582.

Vansteelandt S, Sjölander A. (2016). Revisiting g-estimation of the effect of a time-varying exposure subject to time-varying confounding. Epidemiologic Methods 5(1), 37-56.

Lee W, Sjölander A, Pawitan Y. (2016). A critical look at entropy-based gene-gene interaction measures. Genetic Epidemiology 40(5), 416-424.

Sjölander A. (2016). Regression standardization with the R package stdReg. European Journal of Epidemiology 31(6), 563-574.

Sjölander A, Frisell T, Kuja-Halkola R, Öberg S, Zetterqvist J. (2016). Carry-over effects in sibling comparison designs. Epidemiology 27(6), 852-858.

Sjölander A, Dahlqwist E, Zetterqvist J. (2016). A note on the non-collapsibility of rate differences and rate ratios. Epidemiology 27(3), 356-359.

Zetterqvist J, Vansteelandt S, Pawitan Y, Sjölander A. (2016). Doubly robust methods for handling confounding by cluster. Biostatistics 17(2), 264-276.

Sjölander A. (2016). A cautionary note on the use of attributable fractions in cohort studies. Statistical Methods in Medical Research. 25(6), 2434-2443.

Zetterqvist J, Sjölander A. (2015). Doubly robust estimation with the R package drgee. Epidemiologic Methods 4(1), 69-86.

Kennedy E, Sjölander A, Small D. (2015). Semiparametric causal inference in matched cohort studies. Biometrika 102(3), 739-746.

Sjölander A, Lee W, Källberg H, Pawitan Y. (2014). Bounds on sufficient-cause interactions. European Journal of Epidemiology 29(11), 813-820.

Sjölander A, Lee W, Källberg H, Pawitan Y. (2014). Bounds on causal interactions for binary outcomes. Biometrics 70(3), 500-505.

Sjölander A. (2013). Reducing mean squared error in the analysis of binary paired data. Epidemiologic Methods 2(1), 33–47.

Sjölander A, Greenland S. (2013). Ignoring the matching variables in cohort studies – when is it valid, and why? Statistics in Medicine 32(27), 4696-4708.

Sjölander A, Lichtenstein P, Larsson H, Pawitan Y. (2013). Between-within models for survival analysis. Statistics in Medicine 32(18), 3067-3076.

Orsini N, Bellocco R, Sjölander A. (2013). Doubly robust estimation in generalized linear models. The Stata Journal 13(1), 185-205.

Sjölander A, Bellocco R. (2013). Adjusting for confounding through the blocking of front-doors in longitudinal studies. Epidemiology, Biostatistics and Public Health 10(1), e8757 1-10.

Sjölander A, Johansson ALV, Lundholm C, Altman D, Almqvist C, Pawitan Y. (2012). Analysis of 1:1 matched cohort studies and twin studies, with binary exposures and binary outcomes. Statistical Science 27(3), 395–411.

Sjölander A, Frisell T, Öberg S. (2012). Causal interpretation of between-within models for twin research. Epidemiologic Methods 1(1), 217–237.

Frisell T, Öberg S, Kuja-Halkola R, Sjölander A. (2012). Sibling comparison designs: bias from non-shared confounders and measurement error. Epidemiology 23(5), 713-720.

Sjölander A. (2011). Estimation of attributable fractions using inverse probability weighting. Statistical Methods in Medical Research 20(4), 415-428.

Sjölander A, Vansteelandt S. (2010). Doubly robust estimation of attributable fractions. Biostatistics 12(1), 112-121.

Sjölander A, Vansteelandt S, Humphreys K. (2010). A principal stratification approach to assess the differences in prognosis between cancers caused by hormone replacement therapy and by other factors. The International Journal of Biostatistics Vol. 6 : Iss. 1, Article 20.

Sjölander A. (2009). Bounds on natural direct effects in the presence of confounded intermediate variables. Statistics in Medicine 28, 558-571.

Sjölander A, Humphreys K, Vansteelandt S, Bellocco R, Palmgren J. (2009). Sensitivity analysis for principal stratum direct effects, with an application to a study of physical activity and coronary heart disease. Biometrics 65(2), 514-520.

Sjölander A, Humphreys K, Palmgren J. (2007). On informative detection bias in screening studies. Statistics in Medicine 27, 2635-2650.

Sjölander A, Hössjer O, Werner Hartman L, Humphreys K. (2007). Fine mapping of disease genes using tagging SNPs. Annals of Human Genetics 71(6), 815-827.

Applications

Zeng E, He W, Sjölander A, Bergqvist J, Fang F, Czene K. (In press). Familial adversity: association with discontinuation of adjuvant hormone therapy and breast cancer prognosis. Journal of the National Cancer Institute.

Yang Q, Bränn E, Bertone- Johnson ER, Sjölander A, Fang F, Öberg AS, Valdimarsdóttir UA, Lu D. (In press.) The bidirectional association between premenstrual disorders and perinatal depression: a nationwide register-based study from Sweden. PLOS Medicine.

Oliveira TL, Tang B, Bai G, Sjölander A, Jylhävä J, Finkel D, Pedersen NL, Hassing LB, Reynolds CA, Karlsson IK, Hägg S. (In press.) Effects from medications on functional biomarkers of aging in three longitudinal studies of aging in Sweden. Aging Cell.

Lageborn CT, Zhou M, Boman M, Sjölander A, Larsson H, D’Onofrio BM, Pettersson E, Lichtenstein P, Landén M. (In press). Childhood And Adolescence Outcomes in Offspring to Parents With Bipolar Disorder: The Impact Of lifetime Parental Comorbidity, Parental Sex, And Bipolar Subtype. Journal of Child Psychology and Psychiatry.

Bosi A, Clase CM, Ceriani L, Sjölander A, Fu EL, Runesson B, Chang Z, Landén M, Bellocco R, Elinder CG, Carrero JJ. (In press). Absolute and relative risks of kidney outcomes associated with lithium vs valproate use in Sweden. JAMA Network Open.

Yang Y, Ludvigsson JF, Olén O, Sjölander A, Carrero JJ. (In press). Absolute and relative risks of kidney and urological complications in patients with inflammatory bowel disease. American Journal of Gastroenterology.

Yang Y, Ludvigsson JF, Olén O, Sjölander A, Carrero JJ. (In press). Estimated Glomerular Filtration Rate and the Risk of Inflammatory Bowel Disease in Adults: A Swedish Population-Based Study. Inflammatory Bowel Diseases.

Zhou M, Takami Lageborn C, Boman M, Sjölander A, Larsson H, D’Onofrio B, Landén M, Lichtenstein P, Pettersson P. (In press). Associations between psychiatric diagnoses in parents and psychiatric, behavioral, psychosocial outcomes in their offspring: a Swedish population-based register study. The American Journal of Psychiatry.Mazhar F, Hjemdahl P, Sjölander A, Kahan T, Jernberg T, Carrero JJ. (In press). Intensity of and adherence to lipid-lowering therapy as predictors of goal attainment and major adverse cardiovascular events in primary prevention. American Heart Journal.v

Mazhar F, Hjemdahl P, Sjölander A, Kahan T, Jernberg T, Carrero JJ. (2024). Intensity of and adherence to lipid-lowering therapy as predictors of goal attainment and major adverse cardiovascular events in primary prevention. American Heart Journal 269, 118-130.

Kanina A, Larsson H, Sjölander A, Butwicka A, Taylor M, Martini M, Lichtenstein P, Lundberg F, D’Onofrio B, Rosenqvist M. (2023). Association between cumulative psychosocial adversity in the family and ADHD and autism: a family-based cohort study. Translational Psychiatry 13(1), 282.

Wei H, Zeng E, Sjölander A, Hübbert L, Hedayati E, Czene K. (2023). Concomitant discontinuation of cardiovascular therapy and adjuvant hormone therapy in breast cancer patients. JAMA Network Open 6(7), e2323752.

Tang B, Li X, Wang Y, Sjölander A, Johnell K, Thambisetty M, Ferrucci L, Reynolds C, Finkel D, Jylhävä J, Pedersen N, Hägg S. (2023). Longitudinal associations between uses of antihypertensive, antidiabetic, and lipid-lowering medications and biological aging. GeroScience 45(3), 2065-2078.

Liu B, Svenningsson P, Ludvigsson JF, Lundholm C, Wallin J, Larsson H, Sjölander A, Williams DM, Pedersen NL, Wirdefeldt K. (2023). β2-adrenoreceptor agonists, montelukast, and Parkinson’s disease risk. Annals of Neurology 93(5), 1023-1028.

Barbulescu A, Sjölander A, Delcoigne B, Askling J, Frisell T. (2023). Glucocorticoid exposure and the risk of serious infections in rheumatoid arthritis – a marginal structural model application. Rheumatology 62(10), 3391-3399.

Hu K, Wang J, Sparén P, Herweijer E, Sjölander A, Adami HO, Valdimarsdóttir U, Sundström K, Fang F. (2023). Invasive cervical cancer, precancerous lesion, and cervical screening participation among women with mental illness: a population-based observational study. The Lancet Public Health 8(4), e266-e275.

Hu K, Feychting M, Lu D, Sjölander A, Czene K, Hall P, Fang F. (2023). Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: evidence from a general female population and a mammographic screening cohort in Sweden. Cancers 15(3), 692.

Mazhar F, Sjölander A, Fu EL, Ärnlöv J, Levey AS, Coresh J, Carrero JJ. (2023). Estimating the prevalence of chronic kidney disease while accounting for non-random testing with inverse probability weighting. Kidney International 103(2), 416-420.

Alkas J, Bosi A, Sjölander A, Barany P, Elinder C-G, Fu EL, Carrero JJ. (2023). Novel glucose-lowering drugs and the risk of acute kidney injury in routine care; the Stockholm CREAtinine Measurements (SCREAM) project. Journal of Nephrology 36(3), 705-711.

Yang Q, Lagerberg T, Sjölander A, Bertone-Johnson ER, Fang F, Ye W, Chang Z, Valdimarsdóttir UA, Lu D. (2022). Use of hormonal contraceptives and antidepressants and risks of suicidal behavior and accidents among women with premenstrual disorders: a nationwide cohort study. BMC Medicine 20(1), 482.

Lagerberg T, Sjölander A, Gibbons RD, Quinn PD, D’Onofrio BM, Hellner C, Lichtenstein P, Fazel S, Chang Z. (2022). Use of central nervous system drugs in combination with selective serotonin reuptake treatment: a Bayesian screening study for risk of suicidal behavior. Frontiers in Psychiatry 9(13):1012650.

Shen Q, Song H, Aspelund T, Yu J, Lu D, Jakobsdóttir J, Bergstedt J, Yi L, Sullivan PF, Sjölander A, Ye W, Fall K, Fang F, Valdimarsdóttir U. (2022).  Cardiovascular disease and subsequent risk of psychiatric disorders: a nationwide sibling-controlled study. eLife 11:e80143.

Zeng E, He W, Sjölander A, Bergqvist J, Czene K. (2022). Determinants and effectiveness of extending the duration of adjuvant hormone therapy beyond 5 years in patients with breast cancer. Cancer Research 82(19), 3614-3621.

Mazhar F, Hjemdahl P, Clase CM, Johnel K, Jernberg T, Sjölander A, Carrero JJ. (2022).  Intensity of and adherence to lipid-lowering therapy as predictors of major adverse cardiovascular outcomes in patients with coronary heart disease. Journal of the American Heart Association 11(14), e025813.

Zhao J, Sjölander A, Edgren G. (2022). Mortality of transfused patients in relation to donor sex and parity: a nationwide natural experiment. JAMA Internal Medicine 182(7), 747-756.

Yu R, Långström N, Forsman M, Sjölander A, Fazel S, Molero Y. (2022). Associations between prisoner placement and recidivism: a nationwide longitudinal study. PLOS ONE 17(5), e0267941.

Yang Q, Þórðardóttir EB, Hauksdóttir A, Aspelund T, Jakobsdóttir J, Halldorsdottir T, Tomasson G, Rúnarsdóttir H, Danielsdottir HB, Bertone-Johnson ER, Sjölander A, Fang F, Lu D, Valdimarsdóttir UA. (2022). Association between adverse childhood experiences and premenstrual disorders: a cross sectional analysis of 11,973 women. BMC Medicine 20(1), 60.

Hu K, Smedby KE, Sjölander A, Montgomery S, Valdimarsdóttir U, Engstrand L, Fang F, Fall K. (2022). Use of antibiotics and risk of psychiatric disorders in newly diagnosed cancer patients: a population-based cohort study in Sweden. Cancer Epidemiology, Biomarkers & Prevention 31(3), 528-535.

Shen Q, Sjölander A, Sloan EK, Walker A, Fall K, Valdimarsdottir U, Sparén P, Smedby KE, Fang F. (In press). NSAID use and unnatural deaths after cancer diagnosis: a nationwide cohort study in Sweden. BMC Cancer.

Li Y, Sjölander A, Song H, Cnattingius S, Fang F, Yang Q, Fernández de la Cruz L, Mataix-Cols D, Brander G, Li J, Zhang W, Fall K, D’Onofrio BM, Almqvist C, Lichtenstein P, Valdimarsdóttir UA, Lu D. (2022Shen Q, Sjölander A, Sloan EK, Walker A, Fall K, Valdimarsdottir U, Sparén P, Smedby KE, Fang F. (2022). NSAID use and unnatural deaths after cancer diagnosis: a nationwide cohort study in Sweden. BMC Cancer 22(1), 75.). Associations of parental and perinatal factors with subsequent risk of stress-related disorders: a nationwide cohort study with sibling comparison. Molecular Psychiatry 27(3), 1712-1719.

Zhang R, Sjölander A, Ploner A, Lu D, Bulik CM, Bergen SE. (2022). Novel disease associations with schizophrenia genetic risk revealed in ~400 000 UK Biobank participants. Molecular Psychiatry 27(3), 1448-1454.

Trevisan M, Clase CM, Evans M, Popov T, Ludvigsson JF, Sjölander A, Carrero JJ. (2022). Patterns of chronic and transient hyperkalemia and clinically-important outcomes in patients with chronic kidney disease. Clinical Kidney Journal 15(1), 153-161.

Xu Y, Fu EL, Trevisan M, Jernberg T, Sjölander A, Clase CM, Carrero JJ. (2021). Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes. American Heart Journal 32(2), 424-435.

Trevisan M, Fu EL, Xu Y, Savarese G, Lund LH, Grams ME, Sjölander A, Carrero JJ. (2021). Stopping mineralocorticoid receptor antagonists after hyperkalemia: trial emulation in data from routine care. European Journal of Heart Failure 23(10), 1698-1707.

Chen R, Sjölander A, Johansson S, Lu D, Razaz N, Tedroff K, Villamor E, Cnattingius S. (2021). Impact of gestational age on risk of cerebral palsy: Unravelling the role of neonatal morbidity. International Journal of Epidemiology 50(6), 1852-1863.

Azam S, Eriksson M, Sjölander A, Gabrielson M, Hellgren R, Czene K, Hall P. (2021). Mammographic microcalcifications and risk of breast cancer. British Journal of Cancer 125(5), 759-765.

Yang Q, Sjölander A, Li Y, Viktorin A, Bertone-Johnson ER, Ye W, Fang F, Valdimarsdóttir UA, Lu D. (2021). Clinical Indications of Premenstrual Disorders and Subsequent Risk of Injury: A Population-Based Cohort Study in Sweden. BMC Medicine 19(1), 119.

Toss F, Zhao J, Sjölander A, Edgren G. (2021). Short term health outcomes following whole blood donation: a nationwide, retrospective cohort study. Transfusion 61(8), 2347-2355.

Liu B, Sjölander A, Pedersen N, Ludvigsson J, Chen H, Fang F, Wirdefeldt K. (2021). Irritable bowel syndrome and Parkinson’s disease risk: register-based studies. NPJ Parkinson’s Disease 7(1).

Rania M, Monell E, Sjölander A, Bulik CM. (2021). Emotion dysregulation and suicidality in eating disorders. International Journal of Eating Disorders 54(3), 313-325.

Azam S, Eriksson M, Sjölander A, Gabrielson M, Hellgren R, Czene K, Hall P. (2021). Predictors of mammographic microcalcifications. Cancer Epidemiology 148(5), 1132-1143.

Xu Y, Evans M, Barany P, James G, Sjölander A, Carrero JJ. (2021). Factors affecting pre-end-stage kidney disease haemoglobin control and outcomes following dialysis initiation: a nationwide study. Clinical Kidney Journal 14(7), 1780-1788.

Trevisan M, Fu EL, Szummer K, Norhammar A, Lundman P, Wanner C, Sjölander A, Jernberg T, Carrero JJ. (2021). Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarction. European Heart Journal – Cardiovascular Pharmacotherapy 7(2), 104-111.

Shen Q, Lu D, Andrae B, Schelin MEC, Sjölander A, Cao Y, Sparén P, Fang F. (2020). Risk of injuries around diagnosis of cervical cancer and its precursor lesions: a nationwide cohort study in Sweden. Cancer Epidemiology, Biomarkers and Prevention 29(11), 2230-2234.

Hu K, Sjölander A, Lu D, Walker AK, Sloan EK, Fall K, Valdimarsdóttir U, Hall P, Smedby KE, Fang F. (2020). Aspirin and other non-steroidal anti-inflammatory drugs and depression, anxiety, and stress-related disorders following a cancer diagnosis: a nationwide register-based cohort study. BMC Medicine 18(1), 238.

Chang Z, Quinn PD, O’Reilly L, Sjölander A, Hur K, Gibbons R, Larsson H, D’Onofrio BM. (2020). Medication for Attention-Deficit/Hyperactivity Disorder and risk for suicide attempts. Biological Psychiatry 88(6), 452-458.

Laureati P, Xu Y, Trevisan M, Schalin L, Bellocco R, Sood MM, Barany P, Sjölander A, Evans M, Carrero JJ. (2020). Initiation of sodium polystyrene sulfonate and associated adverse events; a nationwide healthcare-based analysis from the Swedish Renal Register. Nephrology Dialysis Transplantation 35(9), 1518-1526.

Liu B, Wanders A, Wirdefeldt K, Sjölander A, Sachs MC, Eberhardson M, Ye W, Ekbom A, Olén O, Ludvigsson JF. (2020). Vagotomy and the future risk of inflammatory bowel disease: A nationwide register-based matched cohort study. Alimentary Pharmacology & Therapeutics 51(11):1022-1030.

Hultcrantz M, Modlitba A, Vasan SK, Sjölander A, Rostgaard K, Landgren O, Hjalgrim H, Ullum H, Erikstrup C, Kristinsson SY, Edgren G. (2020). Hemoglobin concentration and risk of arterial and venous thrombosis in 1.5 million Swedish and Danish blood donors. Thrombosis Research 186, 86-92.

Wernroth ML, Fall K, Svennblad B, Ludvigsson JF, Sjölander A, Almqvist C, Fall T. (2020). Early childhood antibiotic treatment for otitis media and other respiratory tract infections is associated with risk of type 1 diabetes: a nationwide population register-based study with sibling analysis. Diabetes Care 43(5): 991–999.

Azam S, Eriksson M, Sjölander A, Hellgren R, Gabrielson M, Czene K, Hall P. (2020). Mammographic density change and risk of breast cancer. JNCI 112(4), 391-399.

Shen Q, Jöud A, Schelin MEC, Sjölander A, Cao Y, Sparén P, Fall K, Czene K, Valdimarsdóttir U, Fang F. (2019). Psychiatric disorders and cardiovascular diseases during the diagnostic workup of potential breast cancer: a population-based cohort study in Skåne, Sweden. Breast Cancer Research 21(1), 139.

Azam S, Sjölander A, Eriksson M, Gabrielson M, Czene K, Hall P. (2019). Determinants of mammographic density change. JNCI Cancer Spectrum 3(1), pkz004.

Rosenqvist MA, Sjölander A, Ystrom E, Larsson H, T Reichborn-Kjennerud. (2019). Adverse family life events during pregnancy and ADHD symptoms in five year old offspring. Journal of Child Psychology and Psychiatry 60(6), 665-675.

Bokenberger K, Sjölander A, Dahl Aslan AK, Karlsson IK, Åkerstedt T, Pedersen NL. (2018). Shift work and risk of incident dementia: A study of two population-based cohorts. European Journal of Epidemiology 33(10), 977-987.

Chen R , Wallin AR, Selinus EN, Sjölander A, Fall K, Valdimarsdóttir U, Czene K, Fang F. (2018). Psychiatric disorders among children with parental cancer: a Swedish register-based matched cohort study. Psycho-Oncology 27(7), 1854-1860.

Zhu J, Sjölander A, Fall K, Valdimarsdottir U, Fang F. (2018). Mental disorders around cancer diagnosis and increased hospital admission rate – a nationwide cohort study of Swedish cancer patients. BMC Cancer 18(1), 322.

Song J, Kuja-Halkola R, Sjölander A, Bergen SE, Larsson H, Landén M, Lichtenstein P. Specificity in etiology of subtypes of bipolar disorder: Evidence from a Swedish population-based family study. (2018). Biological Psychiatry 84(11), 810-816.

Lantz M, Sieurin J, Sjölander A, Waldenlind E,  Sjöstrand C, Wirdefeldt K. (2017). Migraine and risk of stroke: a national population-based twin study. Brain 140(10), 2653-2662

Sjörs C, Hedenus F, Sjölander A, Tillander A, Bälter K. (2017). Adherence to dietary recommendations for Swedish adults across categories of greenhouse gas emissions from food. Public Health Nutrition 20(18), 3381-3393.

Lu Y, Sjölander A, Cederlöf M, D’Onofrio BM, Almqvist C, Larsson H, Lichtenstein P. (2017). Association between medication use and performance on higher education entrance tests in individuals with attention-deficit/hyperactivity disorder. JAMA Psychiatry 74(8), 815-822.

Zhu J, Fang F, Sjölander A, Fall K, Adami HO, Valdimarsdóttir U. (2017). First-onset mental disorders after cancer diagnosis and cancer-specific mortality: A nationwide cohort study. Annals of Oncology 28(8), 1964-1969.

Song J, Sjölander A, Joas E, Bergen SE, Runeson B, Larsson H, Landén M, Lichtenstein P. (2017). Suicidal behavior during lithium and valproate medication: a within-individual eight year prospective study of 50,000 patients with bipolar disorder. The American Journal of Psychiatry 174(8), 795-802.

Quinn PD, Chang Z, Hur K, Gibbons RD, Lahey BB, Rickert ME, Sjölander A, Lichtenstein P, Larsson H, D’Onofrio BM. (2017). Attention-deficit/hyperactivity disorder medication and substance-related problems.  The American Journal of Psychiatry 174(9), 877-885.

Gong T, Brew B, Sjölander A, Almqvist C. (2017). Towards non-conventional methods of designing register-based epidemiological studies: an application to pediatric research. Scandinavian Journal of Public Health 45(17_suppl),

Chang Z, Quinn PD, Hur K, Gibbons RD, Sjölander A, Larsson H, D’Onofrio BM. (2017). Association between medication use for attention-deficit/hyperactivity disorder and risk of motor vehicle crashes. JAMA Psychiatry 74(6), 597-603.

Bälter K, Sjörs C, Sjölander A, Gardner C, Hedenus F, Tillander A. (2017). Is a diet low in greenhouse gas emissions a nutritious diet? Archives of Public Health 75, 17.

Chen Q, Kuja-Halkola R, Sjölander A, Serlachius E, Cortese S, Faraone SV, Almqvist C, Larsson H. (2017). Shared familial risk factors between attention-deficit/hyperactivity disorder and overweight/obesity – a population based familial co-aggregation study in Sweden.  Journal of Child Psychology and Psychiatry 58(6), 711-718.

Cederlöf M, Kuja-Halkola R, Larsson H, Sjölander A, Östberg P, Lundström S, Anckarsäter H, Kelleher I, Lichtenstein P. (2017). A longitudinal study of adolescent psychotic experiences and later development of substance use disorder and suicidal behavior. Schizophrenia Research 181, 13-16.

Evans M, Carrero J-J, Bellocco R, Barany P, Qureshi AR, Seeberger A, Jacobson SH, Hylander B, Rotnitzky A, Sjölander A. (2017). Initiation of erythropoiesis-stimulating agents and outcomes: a nationwide observational cohort study in anemic chronic kidney disease patients. Nephrology Dialysis Transplantation 32(11), 1892-1901.

Cesta CE, Viktorin A, Olsson H, Johansson V, Sjölander A, Bergh C, Skalkidou A, Nygren K-G, Cnattingius S, Iliadou AN. (2016). Depression, anxiety, and antidepressant treatment in women:  association with in-vitro fertilization outcome. Fertility and Sterility 105(6), 1594-1602.

Bonn SE, Sjölander A, Tillander A, Wiklund F, Grönberg H, Bälter K. (2016). Body mass index in relation to serum prostate-specific antigen levels and prostate cancer risk. International Journal of Cancer 139(1), 50-57.

Sjörs C, Raposo SE, Sjölander A, Bälter O, Hedenus F, Bälter K. (2016). Diet-related greenhouse gas emissions assessed by a food frequency questionnaire and validated using 7-day weighed food records. Environmental Health 15(1), 15.

Lu D, Sundström K, Sparén P, Fall K, Sjölander A, Dillner J, Helm NY,  Adami HO, Valdimarsdóttir U, Fang F. (2016). Bereavement is associated with an increased risk of HPV infection and cervical cancer: an epidemiological study in Sweden. Cancer Research 76(3), 643-651.

D’Onofrio BM, Class QA, Rickert ME, Sujan AC, Larsson H, Kuja-Halkola R, Sjölander A, Almqvist C, Lichtenstein P, Öberg AS. (2016). Translational epidemiologic approaches to understanding the consequences of early-life exposures. Behavior Genetics 46(3), 315-328.

Yao S, Kuja-Halkola R, Thornton LM, Runfola CD, D’Onofrio BM, Almqvist C, Lichtenstein P, Sjölander A, Larsson H, Bulik CM. (2016). Familial Liability for Eating Disorders and Suicide Attempts: A Population-Based Study in Sweden. JAMA Psychiatry 73(3), 284-291.

Sujan AC, Rickert ME, Class QA, Coyne CA, Lichtenstein P, Almqvist C, Larsson H, Sjölander A, Lahey, BB, van Hulle C, Waldman I, Öberg SA,  D’Onofrio BM. (2016). A genetically informed study of the associations between maternal age at childbearing and adverse perinatal outcomes. Behavior Genetics 46(3), 431-456.

Chen R, Wallin AR, Sjölander A, Valdimarsdóttir U, Ye W, Tiemeier H, Fall K, Almqvist C, Czene K, Fang F. (2015). Childhood injury after a parental cancer diagnosis. eLife 31(4), e08500.

Bonn SE, Bergman P, Lagerros YT, Sjölander A, Bälter K. (2015). A validation study of the web-based physical activity questionnaire Active-Q against the GENEA accelerometer.  JMIR Research Protocols 4(3), e86.

Trinh T, Christensen S, Brand J, Cuzick J, Czene K, Sjölander A, Bälter K, Hall P. (2015). Background risk of breast cancer influences the association between alcohol consumption and mammographic density. British Journal of Cancer 113(1), 159-165.

Trinh T, Eriksson M, Darabi H, Bonn SE, Brand JS, Cuzick J, Czene K, Sjölander A, Bälter K, Hall P. (2015). Background risk of breast cancer and the association between physical activity and mammographic density. Breast Cancer Research 17(1), 50.

Chen R, Sjölander A, Valdimarsdóttir U, Varnum C, Almqvist C, Ye W, Fall K, Czene K, Fang F. (2015). Parental cancer diagnosis and child mortality – a population-based cohort study in Sweden. Cancer Epidemiology 39(1), 79-85.

Bonn SE, Sjölander A, Lagerros YT, Wiklund F, Stattin P, Holmberg P, Grönberg H, Bälter K. (2015). Physical activity and survival among men diagnosed with prostate cancer. Cancer Epidemiology, Biomarkers and Prevention 24(1), 57-64.

Hallböök T, Sjölander A, Åmark P, Miranda M, Bjurulf B, Dahlin M. (2015). Effectiveness of the ketogenic diet used to treat resistant childhood epilepsy in Scandinavia. European Journal of Paediatric Neurology 19(1), 29-36.

Chang Z, Lichtenstein P, D’Onofrio BM, Almqvist C, Kuja-Halkola R, Sjölander A, Larsson H. (2014). Maternal age at childbirth and risk for ADHD in offspring: A population-based cohort study. International Journal of Epidemiology 43(6), 1815-1824.

Sjörs C, Bonn S, Lagerros YT, Sjölander A, Bälter K. (2014). Perceived reasons, incentives, and barriers to physical activity in Swedish elderly men. Interactive Journal of Medical Research 3(4), e15.

Cederlöf M, Bergen SE, Långstrom N, Larsson H, Boman M, Craddock N, Östberg P, Lundström S, Sjölander A, Nordlind K, Landén M, Lichtenstein P. (2014). The association between Darier disease, bipolar disorder and schizophrenia revisited: a population-based family study. Bipolar Disorders 17(3), 340-344.

Pettersson E, Sjölander A, Almqvist C, Anckarsäter H, D’Onofrio BM, Lichtenstein P, Larsson H. (2014). Birth weight as an independent predictor of ADHD symptoms: A within-twin pair analysis. Journal of Child Psychology and Psychiatry 56(4), 453-459.

Chen Q, Sjölander A, Runeson B, D’Onofrio BM, Lichtenstein P, Larsson H. (2014). Drug treatment for Attention-Deficit/Hyperactivity Disorder and suicidal behavior: register based study. BMJ. DOI: 10.1136/bmj.g3769

Bonn SE, Wiklund F, Sjölander A, Szulkin R, Stattin P, Holmberg E, Grönberg H, Bälter K. (2014). Body mass index and weight change in men with prostate cancer: progression and mortality. Cancer Causes and Control 25(8), 933-943.

D’Onofrio BM, Rickert ME, Frans E, Kuja-Halkola R, Almqvist C, Sjölander A, Larsson H, Lichtenstein P. (2014). Paternal age at childbearing and offspring psychiatric and academic morbidity. JAMA Psychiatry 71(4), 432-438.

Chang Z, Lichtenstein P, D’Onofrio BM, Sjölander A, Larsson H. (2014). Serious transport accidents in adults with ADHD, and the effect of medication: A population based study. JAMA Psychiatry 71(3), 319-325.

Chen Q, Sjölander A, Långström N, Rodriguez A, Serlachius E, D’Onofrio BM, Lichtenstein P, Larsson H. (2014). Maternal pre-pregnancy body mass index and offspring Attention-Deficit/Hyperactivity Disorder: a population based cohort study using a sibling-comparison design. The International Journal of Epidemiology 43(1), 83-90.

Christensen SE, Möller E, Bonn S, Ploner A, Wright A, Sjölander A, Bälter O, Lissner L, Bälter K. (2013). Two new meal- and web-based food frequency questionaires: validation of energy and macronutrient intake. Journal of Medical Internet Research 15(6):e109.

Lichtenstein P, Halldner L, Zetterqvist J, Sjölander A, Serlachius E, Fazel S, Långström N, Larsson H. (2012). Medication for attention deficit-hyperactivity disorder and criminality. New England Journal of Medicine 367(21), 2006-2014.

Bonn S, Lagerros YT, Christensen S, Möller E, Wright A, Sjölander A, Bälter KA. (2011). Active Q: Validation of the web-based physical activity questionnaire using doubly labeled water. Journal of Medical Internet Research 14(1), e29.

Sjölander A, Nyren O, Bellocco R, Evans M. (2011). Comparing different strategies for timing of dialysis initiation through inverse probability weighting. American Journal of Epidemiology 174(10), 1204-1210.

Einarsdottir K, Darabi H, Li Y, Low YL, Li, YQ, Bonnard C, Sjölander A, Czene K, Wedren S, Liu, ET, Hall P, Humphreys K, Liu J. (2008). ESR1 and EGF genetic varitation in relation to breast cancer risk and survival. Breast Cancer Research 10(1):R15.

Einarsdottir K, Humphreys K, Bonnard C, Palmgren J, Iles MM, Sjölander A, Li Y, Chia KS, Liu ET, Hall P, Liu J and Wedren S (2006). Linkage disequilibrium mapping of CHECK2: Common variation and breast cancer risk. PLoS Medicine 3(6), e168.

Book chapters

Sjölander A. (2018). Kvantitativa studier: Sambands validitet och reliabilitet. In Grunderna för ett vetenskapligt förhållningssätt inom medicinen, Nyrén O, Garwics M, Nilsson K, Shoshan M (eds), Liber.

Sjölander A. (2016). Attributable fractions. Wiley StatsRef: Statistics Reference Online. 1-7.

Sjölander A, Lindkvist G. (2014). Betydelsen av ursprungssannolikhet vid bevisvärdemetoden. In Festskrift till Christian Diesen, Andersson S, Lainpelto K (eds), Norstedts Juridik.

Sjölander A. (2011). Cross-classifications by joint potential outcomes. In Causal Inference: Statistical Perspectives and Applications, Berzuini C, Dawid P, Bernadinell L (eds), Wiley.

Sjölander A. (2011). The language of potential outcomes. In Causal Inference: Statistical Perspectives and Applications, Berzuini C, Dawid P, Bernadinell L (eds), Wiley.

Sjölander A, Vansteelandt S. (2009). Marginal structural models. In The Encyclopaedic Companion to Medical Statistics, Everitt BS, Palmer C (eds.), Wiley

Short communications

Sjölander A, Paul D. (In press). Why test for proportional hazards – or any other model assumptions? American Journal of Epidemiology.

Sjölander A, Gabriel EE. (In press). Re: E-values for Mendelian randomization. Epidemiology.

Sjölander A, VanderWeele T. (In press). Correction of “Bias factor, maximum bias and the E-value”. International Journal of Epidemiology.

Sjölander A, Kaprio J, Latvala A. (2020). Maternal antenatal corticosteroid treatment and childhood mental and behavioral disorders (comment). JAMA 324(15), 1570.

Sjölander A, Vansteelandt S. (2020). Authors’ reply to “Multiple comparisons controversies are about context and costs, not frequentism vs. Bayesianism”. European Journal of Epidemiology 35(2), 187-191. 

Sjölander A. (2020). An approximate expression for the proportion explained by mediation in survival analysis. Epidemiology 31(2), 21-e22.

Ludvigsson JF, Sjölander A, Murray JA, Hjalgrim H, Edgren G. (2017). Hemoglobin decline before celiac disease diagnosis – a nationwide transfusion cohort study of 1.1 million blood donors. Gut 66(11), 2036-2037.

D’Onofrio BM, Sjölander A, Lichtenstein P. (2014). Fixed effects models and diagnosing psychiatric disorders – reply. JAMA Psychiatry 71(9), 1078-1079.

Pawitan Y, Sjölander A. (2014). Dealing with multiple comparisons: To adjust or not to adjust. Qvintensen 2, 11-14.

Sjölander A. (2013). Klarlägganden om mendelsk randomisering. Läkartidningen, 110: CCEU.

Sjölander A. (2011). Reaction to Pearl’s critique of principal stratification (Invited commentary of “Principal stratification – a goal or a tool?”). International Journal of Biostatistics 7(1), Article 22.

Sjölander A. (2009). Propensity scores and M-structures. Statistics in Medicine 28(9), 1416-1420.

Sjölander A. (2009). Comments on `Formulating the tightest bounds on causal effects in studies with unmeasured confounders’, by Kuroki and Cai. Statistics in Medicine 28(11), 1636-1638.

Sjölander A. (2008). A note on the method of handling non-compliance in clinical trials suggested by Sato/Matsuyama. Statistics in Medicine 27(19), 3920-3924.